Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001764012 | SCV002000263 | uncertain significance | not provided | 2023-02-09 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002503223 | SCV002793831 | uncertain significance | Spermatogenic failure 28; Premature ovarian failure 15 | 2022-04-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004040273 | SCV004868403 | uncertain significance | Inborn genetic diseases | 2024-01-17 | criteria provided, single submitter | clinical testing | The c.3852T>G (p.D1284E) alteration is located in exon 14 (coding exon 14) of the FANCM gene. This alteration results from a T to G substitution at nucleotide position 3852, causing the aspartic acid (D) at amino acid position 1284 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |